Recursion CFO Ben Taylor discusses the state of AI M&A and what companies should look for as the industry moves to new data technologies and systems.

Calling scientific and technological innovation the ‘main battlefield of international strategic competition’, agriculture ...

We recently published an article titled Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025. In this article, we are ...

Artificial intelligence improves process control and reduces the time required to produce key products such as the COVID-19 ...

Last year, more than $7.5 billion globally went to companies applying advances in artificial intelligence to health-related ...

The biotech industry is on a stable growth path, owing to the integration of modern technologies and rapid drug discoveries.

Biotechnology innovations are revolutionizing healthcare with AI, data science, and automation, leading to more precise and ...

Earlier this month, the Trump administration directed the National Institutes of Health (NIH) to impose limits on specific ...

Insilico Medicine ("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, today announced the publication of a novel series of orally available covalent ...

Researchers who have been given access to Google's new AI "co-scientist" tool are enthusiastic about its potential, but it ...

Artificial intelligence (AI) has emerged as an influential technology, driving notable investments across various industries ...

In a recent interview with Fierce Biotech's Chris Hayden, Fortrea's Chief Technology and Data Officer Alaric Jackson ...